{"nctId":"NCT01857206","briefTitle":"Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age","startDateStruct":{"date":"2013-05"},"conditions":["Influenza","Fever"],"count":2055,"armGroups":[{"label":"TIVc","type":"EXPERIMENTAL","interventionNames":["Biological: Mammalian cell based flu vaccine"]},{"label":"TIVf","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Egg based flu vaccine"]}],"interventions":[{"name":"Mammalian cell based flu vaccine","otherNames":[]},{"name":"Egg based flu vaccine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n\\- Healthy subjects 4-17 years of age\n\nExclusion Criteria:\n\n* Subjects who are not healthy,\n* Subjects who are pregnant or breast feeding,\n* Subjects with a history of severe allergic reaction or allergic to any of the vaccine components.","healthyVolunteers":true,"sex":"ALL","minimumAge":"4 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number Of Subjects Reporting Solicited Local and Systemic Adverse Events and Other Indicators Of Reactogenicity After Any Vaccination.","description":"Safety was assessed as the number of subjects who reported solicited local and systemic adverse events and other indicators of reactogenicity following two doses of either mammalian cell culture-derived or egg-derived trivalent influenza vaccination in subjects aged ≥4 To ≤17 Years.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"422","spread":null},{"groupId":"OG001","value":"202","spread":null},{"groupId":"OG002","value":"370","spread":null},{"groupId":"OG003","value":"160","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"109","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"46","spread":null},{"groupId":"OG003","value":"33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"87","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"36","spread":null},{"groupId":"OG003","value":"26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"148","spread":null},{"groupId":"OG001","value":"57","spread":null},{"groupId":"OG002","value":"72","spread":null},{"groupId":"OG003","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"27","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"384","spread":null},{"groupId":"OG001","value":"186","spread":null},{"groupId":"OG002","value":"356","spread":null},{"groupId":"OG003","value":"142","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"252","spread":null},{"groupId":"OG001","value":"110","spread":null},{"groupId":"OG002","value":"267","spread":null},{"groupId":"OG003","value":"113","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"39","spread":null},{"groupId":"OG003","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"26","spread":null},{"groupId":"OG002","value":"45","spread":null},{"groupId":"OG003","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"41","spread":null},{"groupId":"OG002","value":"126","spread":null},{"groupId":"OG003","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"16","spread":null},{"groupId":"OG002","value":"54","spread":null},{"groupId":"OG003","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"128","spread":null},{"groupId":"OG003","value":"57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"34","spread":null},{"groupId":"OG002","value":"109","spread":null},{"groupId":"OG003","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"50","spread":null},{"groupId":"OG003","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"112","spread":null},{"groupId":"OG001","value":"43","spread":null},{"groupId":"OG002","value":"99","spread":null},{"groupId":"OG003","value":"46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"20","spread":null},{"groupId":"OG002","value":"52","spread":null},{"groupId":"OG003","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null},{"groupId":"OG001","value":"29","spread":null},{"groupId":"OG002","value":"24","spread":null},{"groupId":"OG003","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"39","spread":null},{"groupId":"OG003","value":"18","spread":null}]}]}]},{"type":"PRIMARY","title":"Number Of Subjects Reporting Unsolicited Adverse Events After Any Vaccination.","description":"Safety was assessed as the number of subjects who reported unsolicited adverse events following vaccination with either mammalian cell culture-derived or egg-derived trivalent influenza vaccination in subjects aged ≥4 To ≤17 Years.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"277","spread":null},{"groupId":"OG001","value":"139","spread":null},{"groupId":"OG002","value":"158","spread":null},{"groupId":"OG003","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"26","spread":null},{"groupId":"OG002","value":"32","spread":null},{"groupId":"OG003","value":"22","spread":null}]}]}]},{"type":"PRIMARY","title":"Number Of Subjects Reporting Unsolicited Serious Adverse Events After Any Vaccination.","description":"Safety was assessed as the number of subjects who reported serious adverse events (SAEs), medically attended AEs and new onset of chronic diseases (NOCD) in subjects aged ≥4 To ≤17 Years.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"284","spread":null},{"groupId":"OG001","value":"139","spread":null},{"groupId":"OG002","value":"172","spread":null},{"groupId":"OG003","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":17,"n":688},"commonTop":["INJECTION SITE PAIN","INJECTION SITE ERYTHEMA","HEADACHE","MYALGIA","MALAISE"]}}}